Arterial and liver stiffness in patients with non-alcoholic fatty liver disease: hitting two targets with sodium-glucose co-transporter-2 inhibitors

Eur J Gastroenterol Hepatol. 2020 Mar;32(3):460-461. doi: 10.1097/MEG.0000000000001591.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biopsy
  • Elasticity Imaging Techniques*
  • Glucose
  • Humans
  • Non-alcoholic Fatty Liver Disease* / diagnosis
  • Non-alcoholic Fatty Liver Disease* / drug therapy
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Symporters*
  • Vascular Stiffness*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Symporters
  • Sodium
  • Glucose